Khaly Castle’s CFS Untied blog posted notes on the fly, covering the discussion of/presentations on XMRV & blood supply safety as it unfolded at the FDA Blood Products Advisory Committee meeting in Washington today, Dec 14. The opening note, from attendee Heidi Bauer, is titled “XMRV in the Blood Supply Deemed an Acceptable Risk.” (Apparently from paperwork passed out before the meeting.) Scroll down through the "Comments" to read all the updates.
Based on the Panel's 9 to 4 vote at the end of the day to recommend that the FDA ban ME/CFS patient blood donations, the flyer might better be titled “XMRV in the Blood Supply Deemed an Acceptable Risk – NOT”
For immediate top media coverage of the decision, start with the Wall Street Journal ("Advisory Panel Says Victims of Chronic Fatigue Syndrome Be Barred From Donating") and business/financial blog Bloomberg.com, which posted almost immediately after the vote ("Chronic Fatigue [Syndrome] Patients Should Be Barred From Giving Blood, Panel Says").
This follows an announcement last week by the American Red Cross that it was banning ME/CFS patient blood donations.